Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Genmark Diagnostics Ord Shs (NQ: GNMK)
17.44 USD  -1.25 (-6.69%)
Official Closing Price  /  Updated: 7:58 PM EDT, Jul 10, 2020  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,560,000
Open 18.64
Bid (Size) 17.50 (2)
Ask (Size) 18.31 (1)
Prev. Close 18.69
Today's Range 17.36 - 19.09
52wk Range 3.360 - 19.83
Shares Outstanding 55,412,410
Dividend Yield N/A
Performance
YTD
+269.10%
+269.10%
1 Month
+78.51%
+78.51%
3 Month
+181.29%
+181.29%
6 Month
+265.62%
+265.62%
1 Year
+170.81%
+170.81%
Top News
More News
GenMark Diagnostics Provides Preliminary Financial and Operational Results for Second Quarter 2020
Second Quarter 2020 Revenue Expected to Represent Approximately 118% Year-Over-Year Growth Read More
from GlobeNewswire News Releases
GenMark Diagnostics Announces Commercial Launch of its ePlex® Respiratory Pathogen Panel 2 (RP2)
Updated test provides rapid results for SARS-CoV-2 and other important respiratory pathogens and a simplified workflow Read More
from GlobeNewswire News Releases
More News
Read More
GenMark Diagnostics Chosen as Primary Provider of Rapid Diagnostic Testing for Vidant Health
from GlobeNewswire News Releases
GenMark Diagnostics to Participate in Upcoming Investor Conferences
from GlobeNewswire News Releases
Why GenMark Diagnostics Stock Is Soaring Today
category Market News , GNMK
from Motley Fool
Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat
from Investor's Business Daily
Covid Report: Coronavirus Test Maker GenMark Diagnostics Jumps On Sales Beat
from Investor's Business Daily
Dow Jones Rebounds As Apple Hits New High; Alibaba, China Stocks Rally
from Investor's Business Daily
First Week of August 21st Options Trading For GenMark Diagnostics (GNMK)
category Stocks
from Market News Video
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
category OTIC , Biotech , NNVC , and 54 more.
from Benzinga
66 Biggest Movers From Yesterday
category PRTY , RUHN , XENT , and 73 more.
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.